Back to Compound Explorer

Salicin

Clinical trial

Mechanism of Action

Precursor to salicylaldehyde and salicylic acid; anti-inflammatory through COX inhibition
Metabolized to salicylic acid; inhibits COX-1/COX-2; reduces prostaglandin synthesis for analgesia and anti-inflammation
Converted to salicylic acid in intestines; inhibits COX-1/COX-2, reduces prostaglandin synthesis

Research Notes

Salicin undergoes gut bacterial hydrolysis to release salicylic acid. Animal models show anti-inflammatory activity comparable to low-dose aspirin without gastric ulceration risk.

Poplar bark contains salicin at concentrations (4-10%) comparable to white willow, providing similar anti-inflammatory and analgesic effects. Traditional use supports efficacy for arthritis and joint pain; clinical trials show efficacy in musculoskeletal conditions.

Salicin from white willow bark demonstrates anti-inflammatory and analgesic effects comparable to acetylsalicylic acid, though with slower onset due to metabolic conversion requirements. Multiple clinical trials show efficacy for musculoskeletal pain, particularly lower back pain and osteoarthritis. Bioavailability improved when consumed with food.

Found In 3 Herbs

3D Molecular Structure

Phenolic glycoside
Drag to rotate · Click atoms to explore

Salicin

Phenolic glycosideSugar-bound molecules that control drug release in the body

Representative pattern: C₁₁H₁₄O₆

Atoms
Carbon
Oxygen

Related Compounds (Phenolic glycoside)

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.